March 11, 2020 / 7:31 AM / 22 days ago

BRIEF-Stenocare Signs Agreement With Panaxia

March 11 (Reuters) - StenoCare A/S:

* STENOCARE SIGNS AGREEMENT WITH NEW PROMINENT SUPPLIER, PANAXIA AND ANNOUNCES IMMINENT PRODUCT APPROVAL APPLICATION FILING

* COMPANIES ARE AIMING FOR PRODUCT APPROVAL FOR THC OIL, MIXED CBD+THC OIL AND A CBD OIL.

* COMPANY HAS SIGNED A NEW AGREEMENT TO SOURCE MEDICAL CANNABIS PRODUCTS FOR DENMARK AND COMPANY’S INTERNATIONAL MARKETS WITH MARKET LEADING ISRAELI COMPANY PANAXIA PHARMACEUTICAL INDUSTRIES ISRAEL LTD

* PARTNERSHIP IS INTENDED TO EXTEND TO STENOCARE’S INTERNATIONAL MARKETS WHICH ARE BEING EVALUATED AND PREPARED. Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below